Profile: Glycominds Ltd., is a molecular diagnostics company. We develop autoimmune and chronic inflammatory disease management tools & services for the multiple sclerosis market. Our proprietary tests allow physicians to help identify patients at a higher risk for severe disease outcomes. We provide gMS® DX, gMS® Pro CDMS, gMS® Pro EDSS and IBDX®. Our gM® DX test is a blood test for MS biomarkers that helps physicians identify which patients are likely to develop MS. Our gMS® Pro CDMS is a test for use with clinically isolated syndrome patients who have had first neurological event, and help physicians to identify which CIS patients are likely to have a relapse. Our IBDX® panel is the blood test for inflammatory bowel disease diagnosis, stratification and determining Crohn's disease severity. Our gMS® Pro EDSS helps physicians to identify which clinically isolated syndrome & newly diagnosed multiple sclerosis patients will have the likelihood of progressing towards disabilities.
FDA Registration Number: 3004375571
US Agent: Stuart Ringold / Glycominds Llc
Phone: +1-(805)-791-2094 Fax: +1-(805)-577-6792 E-Mail:
5 Products/Services (Click for related suppliers)
|
• Analyte Specific Reagents, Asr Reagents (FDA Code: MVU / 864.4020) Analyte specific reagents (ASR's) are antibodies, both polyclonal and monoclonal, specific receptor proteins, ligands, nucleic acid sequences, and similar reagents which, through specific binding or chemical reaction with substances in a specimen, are intended for use in a diagnostic application for identification and quantification of an individual chemical substance or ligand in biological specimens. ASR's that otherwise fall within this definition are not within the scope of subpart E of this part when they are sold to: |
• Autoimmune Screening Test Panel |
• Autoimmune Test Kits |
• Molecular Diagnostic Services |
• Whole Human Serum (FDA Code: DGR / 866.5700) A whole human plasma or serum immunological test system is a device that consists of reagents used to measure by immunochemical techniques the proteins in plasma or serum. Measurements of proteins in plasma or serum aid in the diagnosis of any disease concerned with abnormal levels of plasma or serum proteins, e.g., agammaglobulinemia, allergies, multiple myeloma, rheumatoid vasculitis, or hereditary angioneurotic edema. |